GBA Blocking Peptide

Catalog no. P-GLCM · Research Use Only

$155 per 250 µg. Ships within 2–3 business days from the U.S.

P-GLCM — affinity-purified Rabbit antibody against GBA. Validated for Immunodepletion, Immunocompetition.

Specifications

Catalog numberP-GLCM
TargetGBA
ApplicationsImmunodepletion, Immunocompetition
ConjugateUnconjugated
ImmunogenRecombinant Glucosylceramidase protein.
Size250 µg
Storage-20°C
UniProtP04062

About this target

Glucosylceramidase that catalyzes, within the lysosomal compartment, the hydrolysis of glucosylceramide/GlcCer into free ceramide and glucose (PubMed:9201993, PubMed:24211208). Thereby, plays a central role in the degradation of complex lipids and the tur. Belongs to the glycosyl hydrolase 30 family. Subcellular location: Lysosome. Expression: Interacts with saposin-C (PubMed:10781797). Interacts with SCARB2 (PubMed:18022370). Interacts with TCP1 (PubMed:21098288). May interact with SNCA; may inhibit the glucosylceramidase activity (PubMed:23266198). Interacts with GRN; this interaction prevent.

Documents

Related products

FabGennix International, Inc., 9191 Kyser Way, Frisco, TX 75033. For research use only. Not for diagnostic or therapeutic use.